Company: MYGN
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0000899923-25-000028
Chunk: 8

Company: MYRIAD GENETICS INC
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 8
---
78 |     |      |
| APPENDIX A- GAAP TO NON-GAAP RECONCILIATION                                                                                                                                |     | A-80 |     |      |
| APPENDIXB- 2017, EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN, AS AMENDED                                                                                       |     | B-84 |     |      |

#### Proxy Summary
This summary highlights information about Myriad Genetics, Inc. and its upcoming 2025 Annual Meeting of Stockholders ("Annual Meeting") contained elsewhere in this proxy statement or in our corporate governance documents published on our website at investor.myriad.com/corporate-governance. This summary does not contain all the information that you should consider, and you should read the entire proxy statement carefully before voting. Page references are provided to help you find further information in this proxy statement.

#### Annual Meeting of Stockholders
| Time and Date: 
 Place:         |     | 8:00 a.m. Mountain Daylight Time on Thursday, June 5, 2025                                                                                                                                                                       
 The Annual Meeting will be a completely virtual meeting. There will be no physical meeting location and the meeting will only be conducted via live webcast at the following address: www.virtualshareholdermeeting.com/MYGN2025 |
|:---------------|:----|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Record Date:   |     | Tuesday, April 8, 2025 (as of the close of business)                                                                                                                                                                             |
| Mailing Date:  |     | This proxy statement was first mailed or made available to stockholders on or about April 9, 2025                                                                                                                                |
| Voting:        |     | Stockholders as of the record date are entitled to vote. Each share of common stock is entitled to one vote for each director nominee and one vote for each of the other proposals                                               |

#### Voting Matters and Board Recommendations
| Proposals                                                                                                                                         |     | Board Vote Recommendation |     | Page  |
| 1. Elect Three Directors                                                                                                                          |     | FOR EACH NOMINEE          |     | P. 68 |
| 2. Ratification of Ernst & Young LLP as our Independent Registered Public Accounting Firm for 2025                                                |     | FOR                       |     | P. 69 |
| 3. Advisory Vote to Approve Executive Compensation                                                                                                |     | FOR                       |     | P. 71 |
| 4. Amendment to 2017 Employee, Director and Consultant Equity Incent